Sinovac Biotech, a China-based pharmaceutical company with headquarters in Beijing. The company focuses specifically on the development and manufacturing of vaccines to target human infectious diseases.This two-dose vaccine is recommended for individuals aged 18 years and above.
It has an efficacy rate of 50.4% for preventing symptomatic infection, according to data from a Brazilian trial, and an effectiveness of 67%, according to a real-world study in Chile.